Who Paid My Doc
TAVR Low Risk
Research payments
$20,979,882
Through program year 2025, $20,979,882 in research payments was reported against TAVR Low Risk, across 3,585 payments.
- Paid by (largest first)
- Medtronic Vascular, Inc.; Medtronic, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $1,130,356 | 364 |
| 2024 | Research | $1,215,016 | 420 |
| 2023 | Research | $1,946,248 | 417 |
| 2022 | Research | $2,844,557 | 415 |
| 2021 | Research | $2,910,202 | 500 |
| 2020 | Research | $3,245,586 | 546 |
| 2019 | Research | $7,687,918 | 923 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Paul Sorajja Minneapolis, MN Named on 84 payments
- Jae Oh Rochester, MN Named on 59 payments
- Jonathan Waks Boston, MA Named on 55 payments
- Judah Askew Minneapolis, MN Named on 51 payments
- Mubashir Mumtaz Harrisburg, PA Named on 41 payments
- Samin Sharma New York, NY Named on 40 payments
- Megan Leary Allentown, PA Named on 40 payments
- Hemal Gada Lemoyne, PA Named on 38 payments
- John Crouch Milwaukee, WI Named on 37 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.